ECE2024 Eposter Presentations Diabetes, Obesity, Metabolism and Nutrition (383 abstracts)
1,2Tunisia; 3Hedi Chaker Hospital, Endocrinology Diabetology, Tunisia; 4Hedi Chaker Hospital, Endocrinology Diabetology, Sfax, Tunisia
Introduction: Medicinal plants and their benefits on human health in the treatment of non-communicable diseases such as hypertension, overweight or obesity, diabetes, and dyslipidemia present a current issue of several research studies. Among these plants is Hibiscus sabdariffa, known for its hypotensive, hypoglycemic, hypolipidemic, and anti-obesity actions. Our work aimed to assess the impact of Hibiscus tea consumption on clinical (systolic and diastolic blood pressures, weight) and biological parameters (blood glucose level, cholesterol level, and triglycerides level) in patients with type 2 diabetes and/or hypertension.
Materials and Methods: Our study involved 20 patients, aged between 18 and 60 years old, who were followed at the Endocrinology-Diabetology department at Hedi Chaker Hospital in Sfax. 55% were females and 45% were males, with a predominance in the age group between 35-40 years. 20% of the subjects had a normal BMI between 18.5 and 25 kg/m2, while the rest of our population had a BMI higher than 25 kg/m2. 25% of the patients were hypertensive, 30% were dyslipidemic, and 25% had both hypertension and dyslipidemia.
Results: In our type 2 diabetic and/or hypertensive patients, our results demonstrate that Hibiscus tea can remarkably modify metabolic parameters. In fact, we observed a significant decrease in blood glucose and glycated hemoglobin levels (47.49% and 9.53%, respectively) as well as a reduction in cholesterol and triglyceride levels by 39.35% and 59.79%, respectively, after one month of tea consumption. Furthermore, we observed an estimated reduction of 17.20% in systolic blood pressure and 9.83% reduction in diastolic blood pressure over the course of one month of treatment.
Conclusion: We can therefore conclude that Hibiscus tea consumption may improve glycemic and lipid profiles, blood pressure, and obesity in patients with type 2 diabetes and/or hypertension. However, further researches involving a larger number of patients are needed to statistically strengthen our results and extrapolate them to the Tunisian population.